Michael Lusk v. HHS - Influenza, Guillain-Barre Syndrome (“GBS”) (2022)

Michael Lusk filed a petition for compensation under the National Vaccine Injury Compensation Program on October 10, 2018, alleging that he suffered Guillain-Barre Syndrome (GBS) after receiving an influenza vaccine. He further alleged that he experienced residual effects for more than six months.

The respondent denied that the flu vaccine caused petitioner's alleged GBS or any other injury, and further denied that his current disabilities are a sequela of a vaccine-related injury. Nevertheless, on March 22, 2022, the parties filed a joint stipulation for damages.

Special Master Daniel T. Horner found the stipulation reasonable and adopted it as the decision of the Court.

Michael Lusk was awarded a lump sum of $30,000.00 as compensation for all items of damages, payable by check to the petitioner. Petitioner's counsel was Danielle Strait of Maglio Christopher & Toale.

Respondent's counsel was Mallori Browne Openchowski of the U.S. Department of Justice.

The public decision does not describe the specific date of vaccination, the specific onset date of GBS, the specific symptoms, diagnostic tests, treatments, or any expert witnesses.